Commentary

Video

What Pharmacists Should Understand When Assessing, Treating Patients With Ovarian Cancer With Rucaparib

Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, discusses what oncology pharmacists should understand about rucaparib when treating ovarian cancer.

Pharmacy Times interviewed Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, on what rucaparib is used to treat and how its mechanism of action works to fight cancer.

During the interview, Morris addressed what oncology pharmacists should understand when assessing and treating patients with ovarian cancer with rucaparib.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
Related Content
Extensive stage-small cell lung cancer (ES-SCLC) -- Image credit: Dr_Microbe | stock.adobe.com
September 15th 2025

Tarlatamab Combination Regimen Demonstrates Potential as Maintenance Therapy in ES-SCLC

Gillian McGovern, Associate Editor
Pharmacy focus oncology Edition, radon and lung cancer
September 15th 2025

A Silent Killer: Unmasking Radon’s Link to Lung Cancer

Alexandra Gerlach, Associate Editor
Man hand holding cocaine or other drugs, drug abuse - Image credit: DedMityay | stock.adobe.com
September 15th 2025

Semaglutide Could Offer Potential Treatment for Cocaine Use Disorder

Kennedy Ferruggia, Assistant Editor
Sifting Through Discordant Data From ESC 2025
September 15th 2025

Sifting Through Discordant Data From ESC 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Abstract luminous DNA molecule. Genetic and gene manipulation concept. Cut of replacing part of a DNA molecule. Medicine. Innovative in science. Medical science and biotechnology.
September 15th 2025

Addressing Adverse Outcomes and Enhancing Patient Care in Gene Therapy

Luke Halpern, Assistant Editor
Panel of health care professionals -- Image credit: Africa Studio | stock.adobe.com
September 15th 2025

Decoding Most Favored Nation: Expert Insights on the Impacts to Patients, Pharma, and Innovation

Brian Corvino Neal Masia, PhD Ali Pashazadeh George Van Antwerp, MBA Ned Milenkovich, PharmD, JD Gillian McGovern, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.